ArticleScientific reports2016

Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling.

Antonina Frolov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.